AI assistant
Sending…
PMV Pharmaceuticals, Inc. — Director's Dealing 2024
Sep 12, 2024
34350_dirs_2024-09-12_22e579b1-2e51-4282-bd4a-af014208b8ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2024-09-11
Reporting Person: Jalota Deepika (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-11 | Common Stock | S | 7218 | $1.5036 | Disposed | 118283 | Direct |
Footnotes
F1: The reported shares were sold to cover the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.
More from PMV Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 9
Interim / Quarterly Report
2025
Nov 12
Regulatory Filings
2025
Nov 12
Major Shareholding Notification
2025
Nov 12
Director's Dealing
2025
Oct 29